Association of PON1 and APOA5 gene polymorphisms in a cohort of indian patients having coronary artery disease with and without type 2 diabetes

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 7-8, 2011, Pages 507-512

  Bhaskar, Seema ^a,b   Ganesan, Mala ^a,b   Chandak, Giriraj Ratan ^a   Mani, Radha ^a   Idris, Mohammed M ^a   Khaja, Nasaruddin ^c   Gulla, Suryaprakash ^d   Kumar, Uday ^e   Movva, Sireesha ^f   Vattam, Kiran K ^g   Eppa, Kavita ^g   Hasan, Qurratulain ^f,g   Pulakurthy, Umamaheshwara Reddy ^b  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b OSMANIA UNIVERSITY   (India)

^c Department of Molecular Biology ^*  (India)

^d CARE HOSPITAL   (India)

^e Yashoda Hospital   (India)

^f Vasavi Medical Research Centre   (India)

^g KAMINENI HOSPITALS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5; ARYLDIALKYLPHOSPHATASE 1;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN PROTEIN INTERACTION;

APOLIPOPROTEINS A; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDIA; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 79960445313     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0207     Document Type: Article

References (39)

1. Agrawal S, Gaurav Tripathi Prajnya R, Nakul Sinha, et al. (2009) Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians. Indian J Med Sci 63:335-344.
2. Birjmohun RS, Vergeer M, Stroes ES, et al. (2009) Both para-oxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study. PLoS ONE 4:e6809.
3. Cabré A, Lázaro I, Girona J, et al. (2009) The APOA5-1131 T>C variant enhances the association between RBP4 and hyper-triglyceridemia in diabetes. Nutr Metab Cardiovasc Dis 20:243-248.
4. Chandak GR, Ward KJ, Yajnik CS, et al. (2006) Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune India compared to Europeans. BMC Med Genet 7:76.
5. Davi G, Santil F (2007) Atherothrombotic disease and the metabolic syndrome Atherothrombotic disease and the metabolic syndrome. Int Congr Ser 1303:74-82.
6. Eichenbaum-Voline S, Olivier M, Jones EL, et al. (2004) Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 24:167-174. (Pubitemid 38082429)
7. Enas EA, Senthilkumar A (2002) Coronary artery disease in Asian Indians: an update and review. Int J Cardiol 1:2.
8. Ganesan M, Bhaskar S, Mani R, et al. (2011) The relationship of ACE and CETP gene polymorphisms with cardiovascular disease in a cohort of Asian Indian patients with and those without type 2 diabetes. J Diabetes Complicat. DOI: 10.1016/j.jdiacomp.2010.10.001.
9. Girona J, Guardiola M, Cabré A, et al. (2008) The apolipoprotein A5 gene-1131T→C polymorphism affects vitamin E plasma concentrations in type 2 diabetic patients. Clin Chem Lab Med 46:453-457. (Pubitemid 351820367)
10. Gluba A, Pietrucha T, Banach M, et al. (2010) The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study. Angiology 61:157-165.
11. Gupta N, Gill K, Singh S (2009) Paraoxonases: structure, gene polymorphism & role in coronary artery disease. Indian J Med Res 130:361-368.
12. Hegele RA (2009) Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet 10:109-121.
13. Huang XS, Zhao SP, Hu M, et al. (2010) Decreased apolipopro-tein A5 is implicated in insulin resistance-related hyper-triglyceridemia in obesity. Atherosclerosis 210:563-568.
14. Hubacek JA (2005) Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants. Clin Chem Lab Med 43:897-902. (Pubitemid 41461136)
15. Hubacek JA, Skodova Z, Adamkova V, et al. (2004) The influence of APOAV polymorphisms (-1131T>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 65:126-130. (Pubitemid 38220113)
16. King H, Aubert R, Herman W (1998) Global burden of diabetes. (1995-2025). Prevalence, numerical estimates and projections. Diabetes Care 21:1414-1431. (Pubitemid 28405191)
17. Koda Y, Tachida H, Soejima M, et al. (2004) Population differences in DNA sequence variation and linkage disequilibrium at the PON1 gene. Ann Hum Genet 68:110-119. (Pubitemid 38379842)
18. Kotur-Stevuljevic J, Spasic S, Jelic-Ivanovic Z, et al. (2008) PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients. Clin Biochem 41:1067-1073.
19. Leviev I, Negro F, James RW (1997) Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of para-oxonase associated with the (Leu-Met54) polymorphism. Ar-terioscler Thromb Vasc Biol 17:2935-2939. (Pubitemid 28016045)
20. Mackness B, Mackness MI, Arrol S, et al. (1998) Serum para-oxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 139:341-349. (Pubitemid 28361819)
21. Mendonça MI, Dos Reis RP, Freitas AI, et al. (2008) Human paraoxonase gene polymorphisms and coronary artery disease risk. Rev Port Cardiol 27:1539-1555.
22. Miller SA, Dykes DD, Polesky HF (1988) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
23. Mirdamadi HZ, Sztanek F, Derdak Z, et al. (2008) The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters. Br J Clin Pharmacol 66:366-374.
24. Mohamed RH, Rasha H, Mohamed Rehab A, et al. (2010) The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease. Clin Biochem 43:553-558.
25. Nabika T, Nasreen S, Kobayashi S, et al. (2002) The genetic effect of the apolipoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis 165:201-204. (Pubitemid 35333346)
26. Oliveira Sousa M, Aĺia P, Pintó X (2008) Apolipoprotein A5 gene: association with triglyceride metabolism and cardiovascular disease. Med Clin (Barc) 130:787-793. (Pubitemid 351839694)
27. Ozkok E, Avdin M, Babalik E, et al. (2008) Combined impact of matrix metalloproteinases-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients. Med Sci Monit 14:CR536-CR542.
28. Pennacchio LA, Olivier M, Hubacek JA, et al. (2002) Two Independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11:3031-3038. (Pubitemid 35414816)
29. Reddy KS (1993) Cardiovascular diseases in India. World Health Stat Q. 46:101.
30. Schaid DJ, Rowland CM, Tines DE, et al. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434. (Pubitemid 34112296)
31. Seda O, Sedova L (2003) New apolipoprotein A-V: comparative genomics meets metabolism. Physiol Res 52:141-146. (Pubitemid 36427816)
32. Shao-Yong S, Jian-hong C, Jian-Feng H, et al. (2005) Paraoxonase gene cluster variation associated with coronary heart disease in Chinese Han women. Chin Med J 118:1167-1174.
33. Singh S, Venkatesh S, Verma JS, et al. (2007) Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus. Indian J Med Res 125:783-787. (Pubitemid 47364465)
34. Szalai C, Keszei M, Duba J, et al. (2004) Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 173:109-114. (Pubitemid 38224202)
35. Taskiran P, Cam SF, Sekuri C et al. (2009) The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease. Turk Kardiyol Dern Ars 37:473-478.
36. Topol EJ, Smith J, Plow EF, et al. (2006) Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15:R117-R123. (Pubitemid 44446784)
37. Wang X, Fan Z, Huang J, et al. (2003) Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population. Arter-ioscler Thromb Vasc Biol 23:328-334. (Pubitemid 36231948)
38. Ward KJ, Shields B, Knight B, et al. (2003) Genetic variants in Apolipoprotein AV alters triglyceride concentrations in preg-nanacy. Lipids Health Dis 2:9.
39. Yu Y, Xue L, Zhao CY (2007) Study on polymorphism in the apolipoprotein A5 gene in patients with premature coronary heart disease. Beijing Da Xue Xue Bao 39:576-580.